GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (NAS:BLFS) » Definitions » Shiller PE Ratio

BLFS (BioLife Solutions) Shiller PE Ratio : (As of Apr. 11, 2025)


View and export this data going back to 1992. Start your Free Trial

What is BioLife Solutions Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioLife Solutions Shiller PE Ratio Historical Data

The historical data trend for BioLife Solutions's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Shiller PE Ratio Chart

BioLife Solutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioLife Solutions Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioLife Solutions's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, BioLife Solutions's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLife Solutions's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioLife Solutions's Shiller PE Ratio falls into.


;
;

BioLife Solutions Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BioLife Solutions's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, BioLife Solutions's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.26/133.1571*133.1571
=0.260

Current CPI (Dec. 2024) = 133.1571.

BioLife Solutions Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -0.090 99.621 -0.120
201506 -0.080 100.684 -0.106
201509 -0.090 100.392 -0.119
201512 -0.090 99.792 -0.120
201603 -0.100 100.470 -0.133
201606 -0.110 101.688 -0.144
201609 -0.080 101.861 -0.105
201612 -0.260 101.863 -0.340
201703 -0.070 102.862 -0.091
201706 -0.060 103.349 -0.077
201709 -0.030 104.136 -0.038
201712 -0.050 104.011 -0.064
201803 -0.010 105.290 -0.013
201806 0.050 106.317 0.063
201809 0.050 106.507 0.063
201812 0.040 105.998 0.050
201903 -1.030 107.251 -1.279
201906 0.020 108.070 0.025
201909 0.350 108.329 0.430
201912 0.020 108.420 0.025
202003 -0.010 108.902 -0.012
202006 -0.700 108.767 -0.857
202009 -0.040 109.815 -0.049
202012 -0.060 109.897 -0.073
202103 -0.030 111.754 -0.036
202106 0.190 114.631 0.221
202109 0.002 115.734 0.002
202112 -0.370 117.630 -0.419
202203 -0.180 121.301 -0.198
202206 -1.720 125.017 -1.832
202209 -0.240 125.227 -0.255
202212 -1.150 125.222 -1.223
202303 -0.320 127.348 -0.335
202306 -0.230 128.729 -0.238
202309 -0.670 129.860 -0.687
202312 -0.330 129.419 -0.340
202403 -0.220 131.776 -0.222
202406 -0.450 132.554 -0.452
202409 -0.040 133.029 -0.040
202412 0.260 133.157 0.260

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioLife Solutions  (NAS:BLFS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


BioLife Solutions Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLife Solutions Business Description

Traded in Other Exchanges
Address
3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Executives
Sarah Aebersold officer: VP, Global Human Resources BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, BOTHELL WA 98021
Amy Duross director 8410 GOLDEN BEAR PLACE, WHISTLER A1 V8E 1J7
Troy Wichterman officer: Chief Financial Officer 3303 MONTE VILLA PARKWAY, BOTHELL WA 98021
Aby J. Mathew officer: Chief Tech. Officer & Sr. VP 3303 MONTE VILLA PARKWAY, #310, BOTHELL WA 98021
Todd Berard officer: Vice President, Marketing 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021
Karen A. Foster officer: Vice President of Operations C/O BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021
Greef Roderick De director
Garrie Richardson officer: Chief Revenue Officer 3303 MONTE VILA PARKWAY, BOTHELL WA 98021
Geraint Phillips officer: SVP, Global Operations 3303 MONTE VILLA, #310, BOTHELL WA 98021
Michael Rice director, officer: President & CEO C/O BIOLIFE SOLUTIONS, INC., 171 FRONT STREET, OWEGO NY 13827
Casdin Partners Master Fund, L.p. 10 percent owner WALKER HOUSE, 87 MARY STREET, GEORGE TOWN E9 KY1-9001
Marcus Schulz officer: Vice President, Global Sales 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021
Joseph C Schick director 16719 NE 139TH PLACE, WOODINVILLE WA 98072
Timothy L. Moore director C/O KITE PHARMA, INC., 2225 COLORADO AVE., SANTA MONICA CA 90404
Joydeep Goswami director SUMITOMO FUDOSAN MITA TWIN BLDG, EAST WING 4-2-8 SHIBAURA MINATO-KU, TOKYO M0 1080023